Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Apogee Therapeutics Inc. (APGE) had Consolidated Net Income/Loss of $-65.02M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-65.02M |
|
-- |
|
-- |
|
$71.28M |
|
$-71.28M |
|
$6.32M |
|
$-64.96M |
|
$-64.96M |
|
$-65.02M |
|
$-65.02M |
|
|
Consolidated Net Income/Loss |
$-65.02M |
$-65.02M |
|
$-71.28M |
|
$-72.49M |
|
58.77M |
|
58.77M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$540.10M |
|
$6.03M |
|
$86.06M |
|
$626.16M |
|
$34.05M |
|
-- |
|
$5.77M |
|
$39.82M |
|
$586.34M |
|
$586.34M |
|
$586.34M |
|
59.48M |
|
| Cash Flow Statement Financials | |
$-164.76M |
|
$109.05M |
|
$21.54M |
|
$142.08M |
|
$107.91M |
|
$-34.17M |
|
$34.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-169.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.09% |
|
-11.09% |
|
-10.38% |
|
-11.09% |
|
$9.86 |
|
$-2.89 |
|
$-2.80 |
|